| Issue Date | Title | Author(s) |
| 2022-01-01 | Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study | Tiller, JM; Cousens, NE; Kaur, R; Rowley, S; Ko, YA; Mahale, S; Bankier, A; Meiser, B; Barlow-Stewart, K; Burnett, L; Jacobs, C; James, P; Trainer, A; Neil, S; Campbell, IG; Andrews, L; Delatycki, M |
| 2023-06-21 | A survey of genetic and palliative care health professionals' views of integrating genetics into palliative care. | White, S; Turbitt, E; Rogers, K; Tucker, K; McEwen, A; Best, M; Phillips, JL; Jacobs, C |
| 2017-09 | Defining personal utility in genomics: A Delphi study. | Kohler, JN; Turbitt, E; Lewis, KL; Wilfond, BS; Jamal, L; Peay, HL; Biesecker, LG; Biesecker, BB |
| 2018-05-01 | Intentions to share exome sequencing results with family members: Exploring spousal beliefs and attitudes | Turbitt, E; Roberts, MC; Ferrer, RA; Taber, JM; Lewis, KL; Biesecker, LG; Biesecker, BB; Klein, WM |
| 2019-01-01 | A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy | Horvat, C; Johnson, R; Lam, L; Munro, J; Mazzarotto, F; Roberts, AM; Herman, DS; Parfenov, M; Haghighi, A; McDonough, B; DePalma, SR; Keogh, AM; Macdonald, PS; Hayward, CS; Roberts, A; Barton, PJR; Felkin, LE; Giannoulatou, E; Cook, SA; Seidman, JG; Seidman, CE; Fatkin, D |
| 2023-09-04 | How do women talk about self-funded breast cancer genetic testing?: Small stories and stance-taking strategies. | Bechaz, A; Sexton, A; Gill, G; Karidakis, M |
| 2020-09 | What do we do and how do we do it? Assessing genetic counselling in the modern era. | Yeates, L; McEwen, A; Ingles, J |
| 2012-12-01 | Genetic variation in the 15q25 nicotinic acetylcholine receptor gene cluster (CHRNA5- CHRNA3-CHRNB4) interacts with maternal selfreported smoking status during pregnancy to influence birth weight | Tyrrell, J; Huikari, V; Christie, JT; Cavadino, A; Bakker, R; Brion, MJA; Geller, F; Paternoster, L; Myhre, R; Potter, C; Johnson, PCD; Ebrahim, S; Feenstra, B; Hartikainen, AL; Hattersley, AT; Hofman, A; Kaakinen, M; Lowe, LP; Magnus, P; McConnachie, A; Melbye, M; Ng, JWY; Nohr, EA; Power, C; Ring, SM; Sebert, SP; Sengpiel, V; Taal, HR; Watt, GCM; Sattar, N; Relton, CL; Jacobsson, B; Frayling, TM; Sørensen, TIA; Murray, JC; Lawlor, DA; Pennell, CE; Jaddoe, VWV; Hypponen, E; Lowe, WL; Jarvelin, MR; Smith, GD; Freathy, RM |
| 2021-08 | Parent clinical trial priorities for fragile X syndrome: a best-worst scaling. | Turbitt, E; D'Amanda, C; Hyman, S; Weber, JD; Bridges, JFP; Peay, HL; Biesecker, BB |
| 2020-11-09 | Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility. | Tudini, E; Davidson, AL; Dressel, U; Andrews, L; Antill, Y; Crook, A; Field, M; Gattas, M; Harris, R; Kirk, J; Pachter, N; Salmon, L; Susman, R; Townshend, S; Trainer, AH; Tucker, KM; Mitchell, G; James, PA; Ward, RL; Mar Fan, H; Poplawski, NK; Spurdle, AB |
